Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase 2 study of sunitinib in refractory thyroid cancer.

Cohen EE, Needles BM, Cullen KJ, Wong SJ, Wade Iii JL, Ivy SP, Villaflor VM, Seiwert TY, Nichols K, Vokes EE. Phase 2 study of sunitinib in refractory thyroid cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6025.

View in: PubMed

collapse authors with profiles